AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2011
Aug 12, 2011
34301_dirs_2011-08-12_aa9129eb-f162-46fb-b536-18b870d7ea04.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-08-12
Reporting Person: Saad Mark E (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-12 | Common Stock | P | 2600 | $3.10 | Acquired | 118600 | Direct |
| 2011-08-12 | Common Stock | P | 400 | $3.12 | Acquired | 119000 | Direct |
| 2011-08-12 | Common Stock | P | 800 | $3.13 | Acquired | 119800 | Direct |
| 2011-08-12 | Common Stock | P | 2700 | $3.14 | Acquired | 122500 | Direct |
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26